Clinical Trials Browser

Phase 2 × Kidney Neoplasms × Erlotinib Hydrochloride × Clear all

NCT01130519 2025-02-21

A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer

Phase 2 Completed

83 enrolled 17 charts

Hereditary leiomyomatosis and renal cell cancer, Carcinoma, Renal Cell, Kidney Neoplasms

NCT00425386 2017-05-03

Sunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney Cancer

Phase 2 Completed

60 enrolled 10 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00193154 2014-04-01

OSI-774 and Bevacizumab in the Treatment of Patients With Metastatic Renal Cell Carcinoma

Phase 2 Completed

Kidney Neoplasms

NCT00045487 2014-01-27

OSI-774

Phase 2 Completed

41 enrolled 7 charts

Carcinoma, Renal Cell, Kidney Neoplasms